Contact
searchSearch
HMP Global

Ulcerative Colitis Topic Center

Featured Content

FDA Alert
FDA Approves Golimumab for Pediatric Ulcerative Colitis
10/08/2025
Rebecca Mashaw
This approval marks the first pediatric indication for golimumab, an antitumor necrosis factor therapy already approved for ulcerative colitis in adults.
This approval marks the first pediatric indication for golimumab, an antitumor necrosis factor therapy already approved for ulcerative colitis in adults.
This approval marks the first...
10/08/2025
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab SC Induction for Ulcerative Colitis
09/22/2025
Rebecca Mashaw
Guselkumab becomes the first and only interleukin-23 inhibitor to offer both subcutaneous and intravenous induction of therapy for ulcerative colitis and Crohn's disease.
Guselkumab becomes the first and only interleukin-23 inhibitor to offer both subcutaneous and intravenous induction of therapy for ulcerative colitis and Crohn's disease.
Guselkumab becomes the first and...
09/22/2025
Advances in Inflammatory Bowel Disease Network
News
Dynamic Changes in Albumin Predict Long-Term Outcomes in Ulcerative Colitis
09/18/2025
Jessica Garlewicz
For practicing gastroenterologists, these findings highlight the value of monitoring early changes in albumin during induction therapy.
For practicing gastroenterologists, these findings highlight the value of monitoring early changes in albumin during induction therapy.
For practicing...
09/18/2025
Advances in Inflammatory Bowel Disease Network
News
Tofacitinib and Ustekinumab Show Comparable Efficacy After Anti-TNF Failure in Ulcerative Colitis
09/18/2025
Jessica Garlewicz
For gastroenterologists managing treatment-refractory UC, these findings support individualized treatment selection based on prior biologic response.
For gastroenterologists managing treatment-refractory UC, these findings support individualized treatment selection based on prior biologic response.
For gastroenterologists managing...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Hypercoagulability Following Hospital Discharge in Severe Ulcerative Colitis
08/21/2025
Rebecca Mashaw
A prospective study highlights sustained thrombotic risk after hospitalization for acute severe ulcerative colitis, underscoring the need for extended vigilance beyond discharge.
A prospective study highlights sustained thrombotic risk after hospitalization for acute severe ulcerative colitis, underscoring the need for extended vigilance beyond discharge.
A prospective study highlights...
08/21/2025
Advances in Inflammatory Bowel Disease Network
News
Mirikizumab Maintains Efficacy, Safety in Ulcerative Colitis
07/24/2025
Rebecca Mashaw
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the...
07/24/2025
Advances in Inflammatory Bowel Disease Network
News
Early Mental Health Improvements Predict Long-Term Remission in UC
07/24/2025
Rebecca Mashaw
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical...
07/24/2025
Advances in Inflammatory Bowel Disease Network
New Algorithm Offers Personalized Infliximab Dosing Strategy to Avert Colectomy in Severe UC
05/08/2025
Riya Gandhi, MA
Pharmacometric modeling enables early prediction of treatment failure in acute severe ulcerative colitis, paving the way for precision infliximab dosing.
Pharmacometric modeling enables early prediction of treatment failure in acute severe ulcerative colitis, paving the way for precision infliximab dosing.
Pharmacometric modeling enables...
05/08/2025
Advances in Inflammatory Bowel Disease Network

News

Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
News
Mirikizumab Maintains Efficacy, Safety in Ulcerative Colitis
07/24/2025
Rebecca Mashaw
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the...
07/24/2025
Advances in Inflammatory Bowel Disease Network
News
Early Mental Health Improvements Predict Long-Term Remission in UC
07/24/2025
Rebecca Mashaw
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical...
07/24/2025
Advances in Inflammatory Bowel Disease Network
News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
02/03/2025
Jessica Garlewicz
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
02/03/2025
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
Jessica Garlewicz
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
Riya Gandhi, MA
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
News
Medicare Will Cover GLP-1s for Obesity Under Deal with Pharma
11/06/2025
Rebecca Mashaw
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said...
11/06/2025
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Updated Indication for Upadacitinib in IBD
10/14/2025
Rebecca Mashaw
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for...
10/14/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Upadacitinib Improves Outcomes in Fistulizing Crohn’s Disease
09/04/2025
Rebecca Mashaw
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Pelvic MRI Detects Subclinical Perianal Disease in Pediatric Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Mirikizumab Improves Quality of Life and Work Productivity in Moderate to Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Guselkumab Demonstrates Efficacy and Safety in Moderate-to-Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and...
09/04/2025
Advances in Inflammatory Bowel Disease Network

Insights

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
Maria Abreu, MD
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the QUASAR Maintenance Study of Guselkumab
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
10/15/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
Phillip Gu, MD, on Acute Severe Ulcerative Colitis
09/07/2024
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the...
09/07/2024
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Video
Gil Melmed, MD, on Comparative Effectiveness in Ulcerative Colitis
09/07/2024
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his...
09/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Erin Forster, MD, MPH; Millie D. Long, MD, MPH; Raymond Cross, MD
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
AIBD Poster Award Winner: Katherine Cates, MD
01/24/2026
Dr Cates describes her award-winning poster on the use of anal pap smears to identify patients at high risk of developing anal cancer and advance them to high-resolution anometry.
Dr Cates describes her award-winning poster on the use of anal pap smears to identify patients at high risk of developing anal cancer and advance them to high-resolution anometry.
Dr Cates describes her...
01/24/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
AIBD Poster Award Winner: Dana Neugut, MD
01/24/2026
Dana Neugut, MD
Dr Neugut reviews her award-winning poster from AIBD on the association of Childhood Opportunity Index with time to infliximab discontinuation in pediatric patients with inflammatory bowel disease.
Dr Neugut reviews her award-winning poster from AIBD on the association of Childhood Opportunity Index with time to infliximab discontinuation in pediatric patients with inflammatory bowel disease.
Dr Neugut reviews her...
01/24/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
AIBD Poster Award Winner: Ece Unal, MD
01/20/2026
Ece Unal, MD
Cleveland Clinic surgery resident Ece Unal, MD, gives an overview of her award-winning poster on a systematic review of excision of skin tags in perianal Crohn’s Disease, presented at the AIBD Annual Meeting.
Cleveland Clinic surgery resident Ece Unal, MD, gives an overview of her award-winning poster on a systematic review of excision of skin tags in perianal Crohn’s Disease, presented at the AIBD Annual Meeting.
Cleveland Clinic surgery...
01/20/2026
Advances in Inflammatory Bowel Disease Network
From the AIBD Open Air Studio
AIBD Poster Award Winner: Wei Wei Lee, MD
01/20/2026
Wei Wei Lee, MD
Dr Lee describes her award-winning poster presentation on the frequency of changes in diagnosis from ulcerative colitis to Crohn's disease among pediatric patients.
Dr Lee describes her award-winning poster presentation on the frequency of changes in diagnosis from ulcerative colitis to Crohn's disease among pediatric patients.
Dr Lee describes her...
01/20/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Raymond Cross, MD, on Ostomy Complications
01/13/2026
Raymond Cross, MD; Sara Horst, MD
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive...
01/13/2026
Advances in Inflammatory Bowel Disease Network
Oriana Damas
From the AIBD Open Air Studio
The Sherman Emerging Leader Award: Oriana Damas, MD
12/29/2025
Oriana Damas, MD, MSCTI
Awarded the Sherman Emerging Leader Prize at the Advances in IBD annual meeting, Dr Oriana Damas encouraged others to use passion, dedication, and vision to move the field forward.
Awarded the Sherman Emerging Leader Prize at the Advances in IBD annual meeting, Dr Oriana Damas encouraged others to use passion, dedication, and vision to move the field forward.
Awarded the Sherman Emerging...
12/29/2025
Advances in Inflammatory Bowel Disease Network
Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
Scott Snapper
From the AIBD Open Air Studio
The Sherman Prize: Scott Snapper, MD
12/29/2025
Scott Snapper, MD
Sherman Prize winner Dr Scott Snapper reviewed his team's work on the genetics associated with IBD in children from the Open Air Studio at the Advances in IBD annual meeting.
Sherman Prize winner Dr Scott Snapper reviewed his team's work on the genetics associated with IBD in children from the Open Air Studio at the Advances in IBD annual meeting.
Sherman Prize winner Dr Scott...
12/29/2025
Advances in Inflammatory Bowel Disease Network
Corey & Miguel
From the AIBD Open Air Studio
Optimize or Switch Therapy? Siegel vs Regueiro Debate
12/23/2025
Miguel D. Regueiro, MD; Corey A. Siegel, MD, MS
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
For the 9th year, Drs Miguel...
12/23/2025
Advances in Inflammatory Bowel Disease Network
Ray Cross and Tina Ha
From the AIBD Open Air Studio
IBD Drive Time: Christina Ha, MD, on Positioning IBD Therapies
12/23/2025
Raymond Cross, MD; Christina Ha, MD
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
In the first-ever video version...
12/23/2025
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Priyam Vora
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Terminal Ileal Resection and CRC Risk
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
Does Hormone Replacement Therapy Affect IBD?
07/18/2025
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Can Perspiration Reveal IBD Biomarkers?
07/18/2025
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Making EHRs Work
07/01/2025
Rebecca Mashaw
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Do EHRs Help or Hinder in IBD Care?
07/01/2025
Rebecca Mashaw
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Advanced Combination Treatment for Refractory IBD
07/01/2025
Rebecca Mashaw
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Hormone Replacement Impact on IBD
05/22/2025
Rebecca Mashaw
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy...
05/22/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Upper GI Crohn's Disease
03/18/2025
Rebecca Mashaw
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Preoperative Nutrition for Crohn’s Disease Patients
03/18/2025
Rebecca Mashaw
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Risk Factors for Surgery in Crohn’s Disease
02/26/2025
Rebecca Mashaw
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that...
02/26/2025
Advances in Inflammatory Bowel Disease Network

Latest News

Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
News
Mirikizumab Maintains Efficacy, Safety in Ulcerative Colitis
07/24/2025
Rebecca Mashaw
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the LUCENT-3 open-label extension highlight durable response and remission rates with mirikizumab.
Three-year data from the...
07/24/2025
Advances in Inflammatory Bowel Disease Network
News
Early Mental Health Improvements Predict Long-Term Remission in UC
07/24/2025
Rebecca Mashaw
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical remission without mental health improvement at week 10 were roughly half as likely to experience endoscopic remission at week 58.
Patients who achieved clinical...
07/24/2025
Advances in Inflammatory Bowel Disease Network
News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
02/03/2025
Jessica Garlewicz
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
02/03/2025
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
Jessica Garlewicz
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
Riya Gandhi, MA
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
News
Medicare Will Cover GLP-1s for Obesity Under Deal with Pharma
11/06/2025
Rebecca Mashaw
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said...
11/06/2025
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Updated Indication for Upadacitinib in IBD
10/14/2025
Rebecca Mashaw
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for...
10/14/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Upadacitinib Improves Outcomes in Fistulizing Crohn’s Disease
09/04/2025
Rebecca Mashaw
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Pelvic MRI Detects Subclinical Perianal Disease in Pediatric Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Mirikizumab Improves Quality of Life and Work Productivity in Moderate to Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Guselkumab Demonstrates Efficacy and Safety in Moderate-to-Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and...
09/04/2025
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Erin Forster, MD, MPH; Millie D. Long, MD, MPH; Raymond Cross, MD
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Podcast
Bruce Sands, MD, on the VEGA Study of Combination Biologic Therapy in UC
12/19/2022
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of...
12/19/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Raymond Cross, MD, on Ostomy Complications
01/13/2026
Raymond Cross, MD; Sara Horst, MD
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive...
01/13/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Conference Coverage
IBD Drive Time: The Best of ACG With Dr Sara Horst
12/01/2025
Raymond Cross, MD; Sara Horst, MD
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive...
12/01/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Freddy Caldera, MD, on Vaccines for Patients With IBD
11/03/2025
Raymond Cross, MD; Freddy Caldera, DO
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to...
11/03/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Megan Riehl, PsyD, on Mental Health and IBD
10/22/2025
Raymond Cross, MD; Megan Riehl, PsyD
Clinical psychologist Megan Riehl, Psy D, talks with IBD Drive Time host Raymond Cross, MD, about the prevalence of anxiety and depression and even post-traumatic stress disorder among patients with inflammatory bowel disease--and how...
Clinical psychologist Megan Riehl, Psy D, talks with IBD Drive Time host Raymond Cross, MD, about the prevalence of anxiety and depression and even post-traumatic stress disorder among patients with inflammatory bowel disease--and how...
Clinical psychologist Megan...
10/22/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Florian Rieder, MD, on Stricturing and Penetrating Crohn's Disease
10/06/2025
Raymond Cross, MD; Florian Rieder
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes...
10/06/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jason Schairer, MD, on Extraintestinal Manifestations in IBD
09/25/2025
Jason Schairer, MD; Raymond Cross, MD
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Host Raymond Cross, MD, and...
09/25/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Ryan Ungaro, MD, on Perturbances in Metabolic Pathways in IBD
09/02/2025
Raymond Cross, MD; Ryan Ungaro
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Dr Raymond Cross discusses with...
09/02/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease
08/18/2025
Raymond Cross, MD; Anita Afzali
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr...
08/18/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Rubin, MD, on the ACG Guidelines for Ulcerative Colitis
08/04/2025
David T. Rubin, MD; Raymond Cross, MD
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD,...
08/04/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Corey Siegel, MD, on Defining Quality Care for IBD
07/15/2025
Raymond Cross, MD; Corey A. Siegel, MD, MS
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Host Raymond Cross, MD, and Dr...
07/15/2025
Advances in Inflammatory Bowel Disease Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use